ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,779Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 807

$383K Total Retail Price of All Prescriptions

Rank: 230 out of 807

588 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 588 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 588 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 6,978 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 341 327 1 1
LISINOPRIL 316 309 2 2
WARFARIN SODIUM 298 274 3 10
FUROSEMIDE 296 282 4 6
HYDROCODONE-ACETAMINOPHEN 292 266 S3 5 15
METOPROLOL SUCCINATE 275 265 6 13
OMEPRAZOLE 272 230 7 4
LEVOTHYROXINE SODIUM 252 250 8 3
AMLODIPINE BESYLATE 226 213 9 5
HYDROCHLOROTHIAZIDE 204 202 10 9
ATENOLOL 204 199 10 7
PREDNISONE 151 139 12 24
METFORMIN HCL 140 136 13 12
TRAZODONE HCL 120 107 14 25
OXYCODONE HCL 116 97 S2 15 53
TAMSULOSIN HCL 110 107 16 27
METOPROLOL TARTRATE 110 95 16 8
ISOSORBIDE MONONITRATE ER 108 101 18 36
ATORVASTATIN CALCIUM 106 90 19 11
PAROXETINE HCL 100 85 20 49
PANTOPRAZOLE SODIUM 98 70 21 44
CITALOPRAM HBR 88 86 22 17
GABAPENTIN 72 46 23 16
GLYBURIDE 72 71 R 23 80
ADVAIR DISKUS 68 55 25 33
FLUTICASONE PROPIONATE 68 58 25 30
LOSARTAN POTASSIUM 67 67 27 14
METHADONE HCL 65 25 S2 28 168
POTASSIUM CHLORIDE 64 59 29 18
PRAVASTATIN SODIUM 62 55 30 21
TRIAMCINOLONE ACETONIDE 62 61 30 98
ZOLPIDEM TARTRATE 58 56 32 23
ALENDRONATE SODIUM 54 54 33 20
CLOPIDOGREL 52 47 34 47
CARVEDILOL 50 50 35 35
SERTRALINE HCL 50 50 35 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.